Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.

Aomar-Millán, Ismael FranciscoSalvatierra, JuanHernández-Quero, José2023-02-092023-02-092021-03-10http://hdl.handle.net/10668/17335enAdrenal Cortex HormonesAntibodies, Monoclonal, HumanizedHumansInterleukin 1 Receptor Antagonist ProteinPneumoniaRetrospective StudiesSARS-CoV-2COVID-19 Drug TreatmentAnakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.research article33694056open access10.1007/s11739-021-02690-31970-9366PMC7945597https://link.springer.com/content/pdf/10.1007/s11739-021-02690-3.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945597/pdf